A market research report on Japan’s apheresis market has been released, compiling market size trends, company developments and segment-level forecasts for 2026–2033. The adoption of membrane filtration technology and education and implementation support from domestic companies are cited as drivers of market growth.
An analysis report on Japan’s apheresis market has been released, covering the Japanese market size, company developments, segment-level forecasts and market shares. The study period runs from 2023 to 2033, with the forecast period covering 2026 to 2033. The market is evaluated by product type, technology, procedure, application and end user.
The expansion of education and training activities by Japanese companies is cited as a growth driver. Asahi Kasei provides therapeutic apheresis training at Apheresis Technology Square, known as A-Square, offering healthcare professionals in Japan and overseas the latest information and practical training. This is expected to support expanded sales of equipment and technology and the spread of clinical expertise.
In terms of technology, membrane filtration is estimated to account for approximately 43.5% of the market, with new technologies emerging after centrifugation becoming more widely adopted. Japanese medical societies have established guidelines for treatment procedures based on membrane filtration, and leading companies are also developing products focused on membrane filtration. The wider adoption of membrane filtration is expected to expand the clinical applications of therapeutic apheresis.
In developments during 2025, Terumo is reported to have launched its latest automated plasma apheresis system in the Japanese market, supported manufacturing infrastructure with an investment of approximately ¥7.8 billion and expanded deployment at major hospitals. In November, SB-KAWASUMI completed the acquisition of a domestic supplier and integrated high-purity filtration technology through an investment of ¥4.3 billion. In October, Asahi Kasei Medical announced the introduction of next-generation filters and an investment of ¥5.1 billion.